ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,980Medicare Part D Prescriptions Filled, Including Refills

Rank: 161 out of 783

$564K Total Retail Price of All Prescriptions

Rank: 214 out of 783

371 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 371 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 371 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 7,784 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LISINOPRIL 458 352 1 4
OMEPRAZOLE 436 296 2 6
AMLODIPINE BESYLATE 362 309 3 5
LEVOTHYROXINE SODIUM 330 254 4 1
FUROSEMIDE 304 279 5 7
SIMVASTATIN 272 223 6 3
HYDROCODONE-ACETAMINOPHEN 271 164 S3 7 2
PRAVASTATIN SODIUM 227 191 8 14
GABAPENTIN 198 107 9 15
METFORMIN HCL 186 142 10 8
ZOLPIDEM TARTRATE 162 118 11 23
WARFARIN SODIUM 158 152 12 10
METOPROLOL TARTRATE 146 118 13 9
METOPROLOL SUCCINATE 144 94 14 13
POTASSIUM CHLORIDE 123 104 15 16
CITALOPRAM HBR 123 95 15 19
PANTOPRAZOLE SODIUM 113 112 17 30
HYDROCHLOROTHIAZIDE 105 89 18 12
CARVEDILOL 105 93 18 21
GLIMEPIRIDE 97 60 20 34
MELOXICAM 97 79 20 37
DICLOFENAC SODIUM 96 57 22 139
OXYCODONE-ACETAMINOPHEN 95 64 S2 23 76
CRESTOR 95 32 23 27
ATORVASTATIN CALCIUM 94 70 25 11
ROPINIROLE HCL 94 56 25 74
FLUTICASONE PROPIONATE 93 55 27 46
DONEPEZIL HCL 89 88 28 24
CLOPIDOGREL 88 60 29 29
METFORMIN HCL ER 86 53 30 64
ATENOLOL 80 44 31 17
KLOR-CON M20 78 63 32 48
AMOXICILLIN 76 50 33 116
OXYCODONE HCL-ACETAMINOPHEN 76 43 S2 33 86
CLONIDINE HCL 75 31 35 60
DOXAZOSIN MESYLATE 73 69 36 87
SPIRIVA 73 62 36 59
CIPROFLOXACIN HCL 72 56 38 62
LEVOFLOXACIN 71 43 39 75
SULFAMETHOXAZOLE-TRIMETHOPRIM 68 45 40 95
LISINOPRIL-HYDROCHLOROTHIAZIDE 68 55 40 33
FLUOXETINE HCL 68 34 40 45
POLYETHYLENE GLYCOL 3350 67 37 43 43
ESTRADIOL 66 32 R 44 204
SPIRONOLACTONE 64 39 45 57
LANTUS 62 50 46 38
AMOX TR-POTASSIUM CLAVULANATE 60 39 47 128
DIGOXIN 58 47 48 61
PROAIR HFA 57 26 49 56
LOSARTAN POTASSIUM 57 50 49 18
PROMETHAZINE HCL 56 40 R 51 97
SERTRALINE HCL 56 41 51 22
RANITIDINE HCL 54 22 53 44
ISOSORBIDE MONONITRATE ER 53 46 54 40
MIRTAZAPINE 53 52 54 52
LOVASTATIN 53 42 54 58
METHOCARBAMOL 52 43 R 57 215
GLYBURIDE 52 40 R 57 111
INSULIN SYRINGE 52 41 57 82
TRAMADOL HCL 51 33 60 20
VENLAFAXINE HCL 50 20 61 233
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 26, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.